Abstract
Objective: To identify causes of refractoriness to oral levothyroxine (LT4) and propose a sequential investigation protocol including gastrointestinal and psychiatric assessments and the LT4 absorption test. Methods: A prospective case series included adults (18–65 years) using ≥2.5 µg/kg/day or ≥250 µg/day of LT4. Ten patients completed full evaluation: medical interview, empirical antiparasitic therapy, upper endoscopy with biopsies, tests for malabsorption and lactose intolerance, psychiatric screening (M.I.N.I. Plus), and a standardized 4-hour LT4 absorption test applying four diagnostic criteria. Results: Most participants were women (80%), mean BMI 28.6 kg/m². At least one contributing factor was identified in 90%. Endoscopic abnormalities were common (80%); half were Helicobacter pylori positive, 40% lactose intolerant, 40% screened positive for depression, and 60% used interfering medications. Based on absorption criteria, three patients had true malabsorption, while most showed adequate LT4 absorption, suggesting pseudo malabsorption linked to nonadherence. Total T4-based criteria yielded the highest concordance, while free T4 and TSH changes were more variable. Conclusion: Refractory hypothyroidism is typically multifactorial. Drug interactions, gastrointestinal disorders, and psychiatric comorbidities frequently impair control. Most patients demonstrated adequate LT4 absorption, highlighting nonadherence as a major cause. A structured, multidisciplinary approach optimizes diagnostic accuracy.
References
BALLA M, et al. Rapid Levothyroxine Absorption Testing: A Case Series of Nonadherent Patients. Int J Endocrinol Metab., 2015; 13(4): e31051.
BENSEÑOR IM, et al. Incidence of thyroid diseases: Results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Arch Endocrinol Metab., 2021; 65(4): 468-78.
BUTT MI, et al. Clinical Application of the Levothyroxine Absorption Test in the Diagnosis of Pseudo-Malabsorption. J Med Case Rep., 2014; 2(11): 253-55.
CARON P, et al. Levothyroxine Absorption Test with the Daily Levothyroxine Dose in Patients With “Refractory Hypothyroidism”. J Endocr Soc., 2025; 9(4): bvaf017.
CHAKER L, PAPALEONTIOU M. Hypothyroidism: A Review. JAMA, 2025; 334(13): 1203.
COUTO B, et al. Thyroid function, autoimmunity, thyroid volume, and metabolic profile in people with Hashimoto thyroiditis. BMC Endocr Disord., 2024; 24(1): 281.
GHOSH S, et al. Levothyroxine Absorption Test to Differentiate Pseudomalabsorption from True Mal-absorption. Eur Thyroid J., 2020; 9(1): 19-24.
GONZALES KM, et al. The Levothyroxine Absorption Test: A Four-Year Experience (2015–2018) at The Mayo Clinic. Thyroid., 2019; 29(12): 1734-42.
HARRINGTON CR, BARGER G. Chemistry of Thyroxine: Constitution and Synthesis of Thyroxine. Biochem J., 1927; 21(1): 169-83.
JONKLAAS J, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid., 2014; 24(12): 1670-1751.
KATZ N. Inquérito Nacional de Prevalência da Esquistossomose mansoni e Geo-helmintoses. Belo Horizonte: CPqRR; 2018.
LIPS DJ, et al. Diagnosis and treatment of levothyroxine pseudomalabsorption. Neth J Med., 2004; 62(4): 114-18.
MAZETO GMFS, et al. Approach to adult patients with primary hypothyroidism in some special situa-tions: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM). Arch Endocrinol Metab., 2022; 66(6): 871-82.
NUGURU SP, et al. Hypothyroidism and depression: a narrative review. Cureus, 2022; 14(8): e28201.
ROBERTSON HM, et al. Factors contributing to high levothyroxine doses in primary hypothyroidism: an interventional audit of a large community database. Thyroid., 2014; 24(12): 1765-71.
SHEEHAN DV, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation. J Clin Psychiatry, 1998; 59(Suppl 20): 22-57.
SHERMAN SI, et al. Sucralfate causes malabsorption of L-thyroxine. Am J Med., 1994; 96(6): 531-35.
SHIMBA R, et al. Pseudo-Malabsorption in High Dose Levothyroxine-Resistant Hypothyroidism. JCEM Case Rep., 2025; 3(6): luaf085.
TORTORA A, et al. Switch from tablet levothyroxine to oral solution resolved reduced absorption by intestinal parasitosis. Endocrinol Diabetes Metab Case Rep., 2019; 19-0026.
VAN WILDER N, et al. Pseudomalabsorption of Levothyroxine: A Challenge for the Endocrinologist in the Treatment of Hypothyroidism. Eur Thyroid J., 2017; 6(1): 52-56.
WALKER JN, et al. A thyroxine absorption test followed by weekly thyroxine administration: a method to assess non-adherence to treatment. Eur J Endocrinol., 2013; 168(6): 913-17.
